Gönül Veliçelebi

6.2k citations

41 papers · 4.9k indexed · 2 hit papers · h-index 24

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 0.5%
Sensory Systems top 0.2%
Physiology top 5%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Michael M. Harpold Kenneth A. Stauderman S.B. Ellis Steven L. Wagner Jack Roos Olga Safrina Kari L. Ohlsen J. Ashot Kozak
Topics: Neuroscience and Neuropharmacology Research (19 papers)Receptor Mechanisms and Signaling (13 papers)Ion channel regulation and function (11 papers)
Cited by: Sensory Systems Cellular and Molecular Neuroscience Molecular Biology
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Switzerland Australia

In The Last Decade

Gönül Veliçelebi

41 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STIM1, an essential and conserved component of store-operated Ca2 + channel function

2005 1.5k citations Jack Roos, Paul J. DiGregorio et al. The Journal of Cell Biology profile →
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

1999 628 citations F. Gasparini, Kurt Lingenhöhl et al. Neuropharmacology profile →

Peers

Countries citing papers authored by Gönül Veliçelebi

Since Specialization

Citations

This map shows the geographic impact of Gönül Veliçelebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gönül Veliçelebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gönül Veliçelebi more than expected).

Fields of papers citing papers by Gönül Veliçelebi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gönül Veliçelebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gönül Veliçelebi. The network helps show where Gönül Veliçelebi may publish in the future.

Co-authorship network of co-authors of Gönül Veliçelebi

This figure shows the co-authorship network connecting the top 25 collaborators of Gönül Veliçelebi. A scholar is included among the top collaborators of Gönül Veliçelebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gönül Veliçelebi. Gönül Veliçelebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CM3457, a potent and selective oral CRAC channel inhibitor, suppresses T and mast cell function and is efficacious in rat models of arthritis and asthma (72.3) 2012 ·The Journal of Immunology ·(unknown),Sergey Grigoryev,(unknown),Jack Roos,(unknown),Kenneth A. Stauderman,Gönül Veliçelebi	11
2	STIM1, an essential and conserved component of store-operated Ca2 + channel functionbreakdown → 2005 ·The Journal of Cell Biology ·Jack Roos,Paul J. DiGregorio,Andriy V. Yeromin,Kari L. Ohlsen,Maria Lioudyno,Shenyuan Zhang,Olga Safrina,J. Ashot Kozak,Steven L. Wagner,Michael D. Cahalan,Gönül Veliçelebi,Kenneth A. Stauderman	1506
3	Family-Based Association between Alzheimer's Disease and Variants inUBQLN1 2005 ·New England Journal of Medicine ·Lars Bertram,Mikko Hiltunen,Michele Parkinson,Martin Ingelsson,Christoph Lange,Karunya Ramasamy,Kristina Mullin,(unknown),Andrew Sampson,(unknown),Kathryn Elliott,Gönül Veliçelebi,(unknown),Bradley T. Hyman,Steven L. Wagner,Kathrin Becker,Deborah Blacker,Rudolph E. Tanzi	184
4	Stable Expression of Human NMDA Receptors in Cultured Mammalian Cells 2003 ·Humana Press eBooks ·Mark A. Varney,Fen‐Fen Lin,Christine Jachec,Sara Rao,Stephen D. Hess,Edwin C. Johnson,Gönül Veliçelebi	4
5	High-throughput assessment of mitochondrial membrane potential in situ using fluorescence resonance energy transfer 2002 ·Mitochondrion ·James A. Dykens,Beth A. Fleck,Soumitra S. Ghosh,(unknown),Gönül Veliçelebi,Manus W. Ward	13
6	Characterization of the recombinant human neuronal nicotinic acetylcholine receptors α3β2 and α4β2 stably expressed in HEK293 cells 2000 ·Neuropharmacology ·Laura E. Chavez-Noriega,Alison Gillespie,Kenneth A. Stauderman,James H. Crona,(unknown),Kathryn Elliott,Richard T. Reid,Tadimeti S. Rao,Gönül Veliçelebi,Michael M. Harpold,Edwin C. Johnson,(unknown)	63
7	[2] Fluorescence techniques for measuring ion channel activity 1999 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Gönül Veliçelebi,Kenneth A. Stauderman,Mark A. Varney,M. Akong,Stephen D. Hess,Edwin C. Johnson	23
8	2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonistbreakdown → 1999 ·Neuropharmacology ·F. Gasparini,Kurt Lingenhöhl,Natacha Stoehr,Peter J. Flor,Micheline Heinrich,Ivo Vranesic,Michel Biollaz,Hans Allgeier,Roland Heckendorn,Stephan Urwyler,Mark A. Varney,Edwin C. Johnson,Stephen D. Hess,Sara Rao,Aida Sacaan,Emily M. Santori,Gönül Veliçelebi,Rainer Kühn	628
9	The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents 1998 ·Life Sciences ·G. Kenneth Lloyd,Frédérique Menzaghi,Bruno Bontempi,Carla M. Suto,Robert D. Siegel,M. Akong,Kenneth A. Stauderman,Gönül Veliçelebi,Edwin C. Johnson,Michael M. Harpold,Tadimeti S. Rao,Aida Sacaan,Laura E. Chavez-Noriega,Mark Washburn,(unknown),Nicholas D. P. Cosford,Leonard A. McDonald	51
10	The Human N‐Methyl‐d‐Aspartate Receptor 2C Subunit: Genomic Analysis, Distribution in Human Brain, and Functional Expression 1998 ·Journal of Neurochemistry ·Lorrie P. Daggett,Edwin C. Johnson,Mark A. Varney,Fen‐Fen Lin,Stephen D. Hess,C Deal,Christine Jachec,Chuanyong Lu,Julie A. Kerner,G. Bernhard Landwehrmeyer,David G. Standaert,A. B. Young,Michael M. Harpold,Gönül Veliçelebi	22
11	Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Mark A. Varney,Sara Rao,Christine Jachec,C Deal,Stephen D. Hess,Lorrie P. Daggett,Fen‐Fen Lin,Edwin C. Johnson,Gönül Veliçelebi	17
12	Functional Characterization of Human N‐Methyl‐d‐Aspartate Subtype 1A/2D Receptors 1998 ·Journal of Neurochemistry ·Stephen D. Hess,Lorrie P. Daggett,C Deal,(unknown),Edwin C. Johnson,Gönül Veliçelebi	28
13	Cellular Distribution of NMDA Glutamate Receptor Subunit mRNAs in the Human Cerebellum 1997 ·Neurobiology of Disease ·Clemens R. Scherzer,G. Bernhard Landwehrmeyer,Julie A. Kerner,David G. Standaert,Zane Hollingsworth,Lorrie P. Daggett,Gönül Veliçelebi,John B. Penney,Anne B. Young	24
14	Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5 1995 ·Neuropharmacology ·Lorrie P. Daggett,Aida Sacaan,M. Akong,Sara Rao,Stephen D. Hess,(unknown),Arturo Urrutia,Christine Jachec,S.B. Ellis,J. Dreessen,Thomas Knöpfel,G. Bernhard Landwehrmeyer,(unknown),A. B. Young,Mark A. Varney,Edwin C. Johnson,Gönül Veliçelebi	102
15	Human neuronal voltage-dependent calcium channels: Studies on subunit structure and role in channel assembly 1993 ·Neuropharmacology ·Paul F. Brust,(unknown),(unknown),C Deal,(unknown),Mark E. Williams,Gönül Veliçelebi,Edwin C. Johnson,Michael M. Harpold	88
16	Structure and functional expression of α1, α2, and β subunits of a novel human neuronal calcium channel subtype 1992 ·Neuron ·Mark E. Williams,Daniel H. Feldman,(unknown),Robert Brenner,Gönül Veliçelebi,S.B. Ellis,Michael M. Harpold	443
17	Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states 1990 ·Regulatory Peptides ·Sally Provow,Gönül Veliçelebi	2
18	Structural Characterization of Vasoactive Intestinal Peptide Receptors from Rat Lung Membranes 1988 ·Annals of the New York Academy of Sciences ·Gönül Veliçelebi,Saraswathi Patthi,Sally Provow,M. Akong,(unknown)	6
19	Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction 1988 ·Biochemistry ·Gary F. Musso,Saraswathi Patthi,(unknown),Sally Provow,E. T. Kaiser,Gönül Veliçelebi	18
20	Specific binding of synthetic human pancreatic growth hormone releasing factor (1–40-OH) to bovine anterior pituitaries 1985 ·Biochemical and Biophysical Research Communications ·Gönül Veliçelebi,(unknown),Michael M. Harpold	39

About Gönül Veliçelebi

Gönül Veliçelebi is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biochemistry, having authored 41 papers that have together received 4.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (13 papers) and Ion channel regulation and function (11 papers). The work is most often cited by research in Sensory Systems (1.3k citations), Cellular and Molecular Neuroscience (2.5k citations) and Molecular Biology (3.3k citations). Gönül Veliçelebi has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Michael M. Harpold, Kenneth A. Stauderman, S.B. Ellis, Steven L. Wagner, Jack Roos, Olga Safrina, Kari L. Ohlsen, J. Ashot Kozak, Shenyuan Zhang and Andriy V. Yeromin. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact